For a Better Understanding of the Bypass Versus Angioplasty in Severe Ischemia of the Leg Trial.
- Author:
Byung Jun SO
1
Author Information
1. Department of Surgery, Wonkwang University College of Medicine, Iksan, Korea. sobjun@wonkwang.ac.kr
- Publication Type:Review
- Keywords:
Bypass versus Angioplasty in Severe Ischemia of the Leg trial;
Intravascular treatment
- MeSH:
Angioplasty;
Ischemia;
Leg;
Ocimum basilicum
- From:Journal of the Korean Society for Vascular Surgery
2011;27(1):1-8
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Non-invasive treatment has been going under active developments and is considered as a prior choice in modern medical circles. It is no exception to the field of vascular surgery. It is rather going under more radical changes. The irreversible trend has come so far, and the Korean Vascular Surgery Society should adapt well to this new environment and try to dominate in intravascular treatment. Therefore, it is crucial to draw interest in the methods of intravascular treatment among the members of our association and to encourage the usage of this method wider and more actively. A lot of vascular surgeons like to quote the results of Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial to self-assure and have pride in the excellency of vascular surgery. However, the current citations are not accurate enough, so it is essential to understand the results of the BASIL trial more exactly to change the current trend of the Korean Vascular Surgery Society and make a huge step forward. This paper will analyse the results of BASIL trial in a more specific and objective way.
